GlaxoSmithKline Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 8.47%133.600.7%$2098.22m
PFEPfizer Inc. 3.80%32.080.9%$1486.52m
MRKMerck & Co., Inc. 6.46%76.360.7%$1377.04m
ABBVAbbVie, Inc. 2.79%74.702.3%$1247.02m
BMYBristol-Myers Squibb Co. 3.50%54.641.0%$1099.95m
LLYEli Lilly & Co. 4.93%140.721.1%$940.58m
FTSVForty Seven, Inc. 0.87%95.370.0%$327.47m
NVSNovartis AG 2.81%81.510.2%$322.71m
GSKGlaxoSmithKline Plc 2.48%37.350.2%$283.54m
AZNAstraZeneca Plc 4.03%44.181.2%$279.13m
NVONovo Nordisk A/S 5.62%59.920.1%$176.22m
SNYSanofi 5.56%44.800.2%$167.14m
BHCBausch Health Cos., Inc. -0.17%14.490.0%$104.00m
RGENRepligen Corp. 3.13%95.457.1%$74.75m
RETAReata Pharmaceuticals, Inc. 3.50%155.243.4%$69.89m

Company Profile

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.